Jane Street
RVPH

Jane Street’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Jane Street’s Portfolio RVPH Stock Details RVPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-44,737
Closed -$250K – 12806
2025
Q4 		$250K Buy
44,737
+33,330
+292% +$371K ﹤0.01% 9248
2025
Q3 		$84.1K Buy
+11,407
New +$97K ﹤0.01% 10205
2025
Q2 		– Sell
-2,246
Closed -$35K – 10717
2025
Q1 		$42.8K Buy
+2,246
New +$70.6K ﹤0.01% 9039
2024
Q2 		– Sell
-1,505
Closed -$114K – 10085
2024
Q1 		$114K Buy
1,505
+50
+3% +$3.96K ﹤0.01% 8483
2023
Q4 		$150K Buy
+1,455
New +$131K ﹤0.01% 8395
2022
Q4 		– Sell
-859
Closed -$27K – 10007
2022
Q3 		$27K Buy
+859
New +$23.7K ﹤0.01% 9122

Other funds holding RVPH

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WAM
Warberg Asset Management Winnetka, Illinois $551M AUM 34.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Jane Street's RVPH Position: Q1 2026 in Review

Jane Street sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q1 2026, closing a stake of 44,737 shares — an estimated $250K sold.

Jane Street first reported a position in RVPH in Q3 2022 and held it in 6 quarters. The position peaked at $250K in Q4 2025. 35 funds tracked by Wall St. Rank hold RVPH as of Q1 2026.

  • Jane Street reported no remaining REVIVA PHARMA HLDGS INC position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 44,737 REVIVA PHARMA HLDGS INC shares in Q1 2026, an estimated $250K.
  • Jane Street first reported a position in REVIVA PHARMA HLDGS INC in Q3 2022 and held it in 6 quarters.
  • Jane Street's REVIVA PHARMA HLDGS INC position peaked at $250K in Q4 2025.
  • 35 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.